According to the recent Nasscom-Zinnov report, by 2024, India’s Global Capability Centers (GCCs) will have grown to 1,700, generating $64.6 billion in export revenue and employing over 1.9 million people. Notably, over 15% of these employees are in the healthcare and life sciences sectors.
Indian GCCs in healthcare are leading the efforts in drug discovery and development by harnessing computational chemistry, bioinformatics, and AI-driven platforms. These centres are accelerating the R&D of new drugs and bringing them to market faster than ever before.
By integrating advanced analytics and data-driven insights, Indian GCCs are making significant contributions to global healthcare innovation, improving patient outcomes on a broader scale.
In an exclusive conversation with AIM, Balasubramanian Sankaranarayanan, the CEO & president of Thryve Digital LLP, said, “In healthcare GCCs, we focus on a specific vertical, dedicating our entire efforts to it. Our goal is to find individuals deeply engaged in healthcare and provide them with opportunities to …